期刊文献+

N-三甲基壳聚糖包衣多柔比星脂质体肿瘤新生血管靶向性的体内评价 被引量:3

Evaluation of in vivo Tumor Angiogenesis Targeting of Adriamycin Cationic Liposomes Coated by N-trime-thyl Chitosan
下载PDF
导出
摘要 目的:考察N-三甲基壳聚糖(TMC)包衣的多柔比星(ADM)阳离子脂质体抗肿瘤活性及对肿瘤新生血管的靶向性。方法:采用动物移植性肿瘤实验法,建立小鼠H_(22)肿瘤模型,比较TMC包衣脂质体组和其他各给药组的肿瘤抑制率并通过小鼠尾静脉注射异硫氰酸荧光素标记的葡聚糖(FITC-Dextran),分析肿瘤组织中的在体荧光,定性观察肿瘤新生血管的形态排布情况,定量测定肿瘤组织中的血管相对密度。结果:TMC包衣的ADM脂质体组,其小鼠的瘤重抑制率达53.47%,显著高于游离药物组和未包衣脂质体组(8.75%,34.88%)(P<0.05);给予TMC包衣ADM脂质体的小鼠,其肿瘤新生血管形态良好,排布均匀,血管分支少,而其他给药组的肿瘤新生血管多扭曲,粗细不均,一个节点有多个血管分支等;通过比较不同给药组肿瘤组织黏附的FITC-Dextran量,TMC包衣ADM脂质体组的肿瘤血管密度明显低于游离药物组和未包衣脂质体组(P<0.05)。结论:TMC包衣的ADM阳离子脂质体不仅具有较强的抗肿瘤活性,而且具有很好的肿瘤新生血管靶向性。 To study the anti-tumor activity and the tumor angiogenesis targeting of adriamycin (ADM) cationic lipo- somes coated by N-trimethyl chitosan (TMC). Method: The mice H22 tumor model was established by animal transplanted tumor experiment. In addition to compare the tumor inhibition rate of liposomes coated by TMC with that of the other experimental groups, the fluorescence in tumor tissue was also investigated through the tail vein injection of fluorescein isothiocyanate conjugated dextran ( FITC- Dextran). The shape and arrangement conditions of tumor angiogenesis were observed qualitatively and relative density of tumor angio- genesis was also determined quantitatively. Result: The tumor weight inhibition rate of the mice given TMC-coated ADM liposomes was 53.47% ,which was significantly higher than that of free drug group and the uncoated liposomes group (8.75% and 34. 88% ,respec- tively) (P 〈 0. 05 ). In the mice given TMC-coated ADM liposomes, the tumor angiogenesis had good shape, uniform arrangement and small vascular branches,while the tumor angiogenesis of the other treatment groups showed more distorted shape, uneven thickness and a node with multiple vascular branches. The vascular density of liposomes coated by TMC was significantly lower than that of the free drug group and uncoated liposomes ( P 〈 0. 05 ). Conclusion : ADM liposomes coated by TMC not only have strong anti-tumor activity, but also have good tumor angiogenesis targeting ability.
出处 《中国药师》 CAS 2011年第7期911-914,共4页 China Pharmacist
关键词 N-三甲基壳聚糖 多柔比星 阳离子脂质体 肿瘤新生血管 肿瘤抑制率 靶向性 N-trimethyl chitosan Adriamycin Cationic liposomes Tumor angiogenesis Tumor inhibition rate Targeting
  • 相关文献

参考文献11

二级参考文献72

  • 1何文,张冕,代文兵,吴燕.N-三甲基壳聚糖透皮吸收促进作用的初步研究[J].中国药学杂志,2006,41(7):519-522. 被引量:26
  • 2Sandri G, Rossi S, Bonferoni MC, et al. Buccal penetration enhancement properties of N-trimethyl chitosan : Influence of quaternization deggre on absorption of a high molecular weight molecule [ J ]. International Journal of Pharrnaceutics, 2005,297 : 146-155.
  • 3Jonker C, Hamman JH, Kotze AF. Intestinal paracellular permeation enhancement with quatemised chitosan : in situ and in vitro evalution [ J ]. International Journal of Pharmaceutics ,2002,238:205-213.
  • 4Snyman D, Hamman JH, Kotzen JS, et al. The relationship between absolute molecular weight and the degree of quatemization of N-trimethyl chitosan chloride [ J ]. Carbohydrate Polymers ,2001,50 : 145-150.
  • 5Sieval AB, Thanou M, Kotze AF ,et al. Preparation and NMR-characterization of highly substituted N-trimethyl chitosan chloride [ J ] . Carbohydrate Polymers, 1998,36 : 157-165.
  • 6USP[S].22thed.1990.2069.
  • 7Gao X, Huang L. A novel cationic liposome reagent for efficient transfection in mammalian cells [ J ]. Biochem Biophys Res Commun, 1991,179 (1) :280.
  • 8Lv HT, Zhang SB, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery [ J ]. J Control Releoze ,2006 ,114 : 100.
  • 9Carreno-Gomez B, Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres[ J]. Int J Pharm,1997,148(2) :231-240.
  • 10Harrington KJ, Rowlinson-Busza G, Syrigos KN. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies [J]. Br J Cancer, 2000,83(2):232-238.

共引文献69

同被引文献27

  • 1Guo XX, He W, Wang XQ, et al. Preparation and efficacy of tumor vasculature-targeted doxorubicin cationic liposomes coated by N-trimethyl chitosan [ J ]. J Applied Polym Sci, 2011,121:2149-2156.
  • 2Zhang C, Qu GW, Sun YJ, et al. Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs [ J ]. Pharmaceut Sci, 2008,33:415-423.
  • 3Garrec DL, Gori S, Luo L, et al. Poly(N-vinylpyrrolidone)-block-po- ly(d, 1-1actide) as a new polymeric solubilizer for hydrophobic anti- cancer drugs : in vitro and in vivo evaluation [ J ]. J Control Release, 2004, 99:83-101.
  • 4Kean T, Thanou M. Biodegradation, distribution and toxicity of chitosan[J]. Adv Drug Delivery Rev, 2010,62( 1 ):3-11.
  • 5Zhao Z, He M, Yin L, et al. Biodegradahle nanoparticles based on linoleic acid and poly (beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs [J]. Biomacromolecules,2009,10(3) :565 -572.
  • 6Wang YS,Liu LR,Jiang Q,et al. Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin[J]. Eur Polym J,2007 ,43(1) :43 -51.
  • 7Kwon S, Park JH, Chung H, et al. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5,B-cholanic acid [J]. Langmuir, 2003, 19 ( 24 ) : 10 188 - 10 193.
  • 8Park JH, Kwon S, Nam JO, et al. Self-assembled nanoparticles based on glycol chitosan bearing 5 [beta] -cholanic acid for RGD peptide delivery [J]. J Control Release ,2004 ,95 (3) :579 - 588.
  • 9Sang Yoo H,Eun Lee J,Chung H,et al. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery[J]. J Control Release,2005 ,103( 1) :235 -243.
  • 10Eichhorn ME, Strieth S, Dellian M. Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives [J]. Drug Resist Updat,2004,7(2) :125 -138.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部